Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0002046701-26-000001
Filing Date
2026-01-08
Accepted
2026-01-08 20:42:41
Documents
1
Period of Report
2026-01-07

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3548
  Complete submission text file 0002046701-26-000001.txt   5354
Mailing Address 2430 N. HALSTED ST. CHICAGO IL 60614
Business Address 2430 N. HALSTED ST. CHICAGO IL 60614 847-673-1707
EXICURE, INC. (Issuer) CIK: 0001698530 (see all company filings)

EIN.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 99-13 MASAN-GIL, MIYANG-MYEON ANSEONG-SI, GYEONGGI-DO MA 17601
Business Address 99-13 MASAN-GIL, MIYANG-MYEON ANSEONG-SI, GYEONGGI-DO MA 17601 821062202280
Exicure HiTron Inc. (Reporting) CIK: 0002046701 (see all company filings)

State of Incorp.: M5 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39011 | Film No.: 26521140